
News|Articles|September 29, 2026
PBM Satisfaction Stalls as Net Promoter Score Turns Negative
Author(s)Maggie L. Shaw
Fact checked by: Giuliana Grossi
The NPS index, ranging from –100 to +100, serves as a proxy for customers’ willingness to recommend products and services they themselves have used.
Advertisement
Advertisement
Employer and health plan satisfaction with pharmacy benefits managers (PBMs) has plateaued near its lowest point in a decade, while a separate loyalty measure shows a more striking change: Net Promoter Score (NPS) for PBMs has swung from +18 in 2022 to –13 in 2026. These findings come from the new Pharmacy Benefit Manager Customer Satisfaction Report published online today,1 which surveyed 250 benefits leaders about their willingness to recommend a product or service they themselves have used.2
Related to this article

A traditional Medicare out-of-pocket (OOP) cap could reduce beneficiaries’ costs but increase annual federal spending by $39 billion to $96 billion.

CMS finalized the mandatory GLOBE Model, tying Part B drug rebates to international prices in areas covering 25% of beneficiaries from Jan. 1, 2027.

Panelists ask whether cancer care will shift toward home-administered infusions as payers push for change. Other topics in this forward-looking session include new delivery tech and practice-led solutions.

CMS finalized Transparency in Coverage updates as a researcher warns ghost rates and missing inpatient data limit payer price files.

FDA accepted United Therapeutics' sNDA for inhaled treprostinil in IPF. Here's what it could mean for patient access, coverage, and costs

Sustainable models require asking what a result shows, what design produced it, and whether the design was built to measure value or just produce a number.

Build scalable obesity care with multidisciplinary teams, clear triage, and monitoring protocols; address GLP-1 gaps, Medicare access and price barriers, including oral GLP-1.
Advertisement
Advertisement

